+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS



Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS



Scandinavian Journal of Infectious Diseases 27(3): 217-220



In a prospective, randomized open-label trial, the efficacy of sulfamethoxazole-trimethoprim (SMX-TMP) 400/80 mg b.i.d. was compared with the efficacy of aerosolized pentamidine (AP) 60 mg every 2nd week as secondary prophylaxis (SP) against recurrence of Pneumocystis carinii pneumonia (PCP) in AIDS patients. 94 patients participated in the study, 47 in each group. The patients were observed for a mean period of 17.2 months. PCP recurred in the AP group in 8 cases, while 1 relapse occurred in the SMX-TMP group. The one-year cumulative relapse rate was 9.0% (95% CI 0-19%) in the AP group compared with 2.4% (95% CI 0-8%) in the SMX-TMP group (p < 0.05). The odds ratio was 4.2 (95% CI 0.5-39.8) in favour of SMX-TMP. Furthermore, we found a tendency towards a protective effect against toxoplasmosis in the SMX-TMP group, though there was no difference in survival between the two groups. There was no statistical difference in frequency of crossover from one therapy form to the other. Based on these data we recommend SMX-TMP for secondary PCP prophylaxis.

(PDF emailed within 0-6 h: $19.90)

Accession: 009295668

Download citation: RISBibTeXText

PMID: 8539544

DOI: 10.3109/00365549509019012



Related references

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. New England Journal of Medicine 327(26): 1842-1848, 1992

Trimethoprim sulfamethoxazole t s versus aerosolized pentamidine ap for primary prophylaxis of pneumocystis carinii pneumonia pcp a prospective randomized controlled clinical trial. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 356, 1992

Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: A prospective, randomized, controlled clinical trial. Journal of Acquired Immune Deficiency Syndromes 7(5): 457-462, 1994

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. AIDS Forschung 8(4): 178, 1993

Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses. Journal of Acquired Immune Deficiency Syndromes 7(5): 457-462, 1994

Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. Aids 6(2): 165-171, 1992

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. New England Journal of Medicine 327(26): 1836-1841, 1992

Aerosolized pentamidine versus trimethoprim sulfamethoxazole tmp smx for acute pneumocystis carinii pneumonia pcp a randomized double blind trial. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 201, 1989

Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial. Aids 6(3): 301-305, 1992

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. AIDS Forschung 8(4): 177-178, 1993

Aerosolized pentamidine compared to trimethoprim/sulfamethoxazole for Pneumocystis carinii pneumonia prophylaxis following orthotopic liver transplantation. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 492, 2000

Evaluation of trimethoprim sulfamethoxazole tmz vs aerosolized pentamidine ap with concomitant on set of zidovudine zdv in primary pneumocystis carinii pneumonia pcp prophylaxis. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 243b, 1991

Aerosolized pentamidine vs trimethoprim sulfamethoxazole for acute pneumocystis carinii pneumonia a randomized double blind trial. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Thb 395, 1990

Aerosolized pentamidine in the long term secondary prophylaxis pneumocystis carinii pneumonia pcp in aids patients. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 229b, 1991